Cymbalta For Anxiety
The U.S. Food and Drug Administration has approved Cymbalta for the treatment of generalized anxiety disorder. Cymbalta is an antidepressant used to treat both major depressive disorder and diabetic neuropathic pain.
Read moreMore information on "Cymbalta For Anxiety"
From Our Experts
Antidepressants: Cymbalta
You've probably seen the television commercials or magazine ads for Cymbalta, and you might be wondering what makes it different from other... Read more »
Drug Alert System Designed by FDA
The Food and Drug Administration (FDA) recently began posting a listing of prescription medications that may have potential risks or safety... Read more »
Will Cymbalta Become the Second Drug Approved for Fibromyalgia?
Eli Lilly and Co. recently submitted a supplemental new drug application to the U.S. Food and Drug Administration requesting that Cymbalta... Read more »
Cymbalta Study Shows Reduction in Chronic Low Back Pain
If Cymbalta (duloxetine) sounds familiar, it may be because it recently received FDA approval for the management of fibromyalgia. Now a... Read more »
Cymbalta Hits a Bump in Its Road to FDA Approval
It has long been thought that Cymbalta (generic name duloxetine) would be the second medication to receive FDA approval for the treatment... Read more »
From Our Sources
Cymbalta improves functioning in some anxiety patients
Cymbalta may help improve functioning in patients with generalized anxiety disorder (GAD), a new study suggests. Florida scientists found that GAD... Read more »
Cymbalta Oral Uses and How to Use
Source: First DataBank
Generic Name: DULOXETINE - ORAL Pronounced: (dull-OX-eh-teen) Uses Duloxetine is used to treat major depression and anxiety. In addition,... Read more »
FDA Approves Cymbalta for Chronic Joint, Muscle Pain
The antidepressant Cymbalta (duloxetine hydrochloride) has been approved by the U.S. Food and Drug Administration for the treatment of chronic... Read more »
Cymbalta's package, label changed to cut errors
The U.S. Food and Drug Administration has announced changes in the packaging and labeling for Cymbalta. The packaging changes are designed to cut... Read more »
FDA asked to consider Cymbalta for chronic pain
Drugmaker Eli Lilly & Co. has asked the U.S. Food and Drug Administration to approve Cymbalta for the management of chronic pain. Lilly's... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
